{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:50:13Z","timestamp":1787017813931,"version":"build-2736575974"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"17","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recent studies in mice have shown a role for the canonical WNT pathway in lymphocyte development. Because cancers often arise as a result of aberrant activation of signaling cascades that normally promote the self-renewal and expansion of their progenitor cells, we hypothesized that activation of the WNT pathway might contribute to the pathogenesis of lymphoproliferative disease. Therefore, we screened a large panel (n = 162) of non\u2013Hodgkin lymphomas (NHL), including all major WHO categories, for nuclear expression of \u03b2-catenin, a hallmark of \u201cactive\u201d WNT signaling. In 16 lymphomas, mostly of T-lineage origin, nuclear localization of \u03b2-catenin was detected. Interestingly, some of these tumors contained established gain-of-function mutations in the gene encoding \u03b2-catenin (CTNNB1); however, in the majority, mutations in either CTNNB1 or APC were not detected. Functional analysis of WNT signaling in precursor T-lymphoblastic lymphomas\/leukemias, the NHL subset in which \u03b2-catenin accumulation was most prevalent (33% positive), revealed a constitutively activated, but still responsive, WNT pathway, which controlled T-cell factor\u2013mediated gene transcription and cell growth. Our data indicate that activation of the WNT pathway, either by CTNNB1 mutation or autocrine stimulation, plays a role in the pathogenesis of a subset of NHLs, in particular, those of T-cell origin. [Cancer Res 2008;68(17):6969\u201377]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-1322","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T00:53:55Z","timestamp":1219971235000},"page":"6969-6977","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Illegitimate WNT Pathway Activation by \u03b2-Catenin Mutation or Autocrine Stimulation in T-Cell Malignancies"],"prefix":"10.1158","volume":"68","author":[{"given":"Richard W.J.","family":"Groen","sequence":"first","affiliation":[{"name":"1Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique E.C.M.","family":"Oud","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther J.M.","family":"Schilder-Tol","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije B.","family":"Overdijk","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derk","family":"ten Berge","sequence":"additional","affiliation":[{"name":"2Howard Hughes Medical Institute and Department of Developmental Biology, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Nusse","sequence":"additional","affiliation":[{"name":"2Howard Hughes Medical Institute and Department of Developmental Biology, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Spaargaren","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Pals","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,8,28]]},"reference":[{"key":"2022061700300812900_B1","doi-asserted-by":"crossref","unstructured":"Evans LS, Hancock BW. Non-Hodgkin lymphoma. Lancet\u20082003; 362: 139\u201346.","DOI":"10.1016\/S0140-6736(03)13868-8"},{"key":"2022061700300812900_B2","doi-asserted-by":"crossref","unstructured":"Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer\u20082005; 5: 251\u201362.","DOI":"10.1038\/nrc1589"},{"key":"2022061700300812900_B3","doi-asserted-by":"crossref","unstructured":"Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood\u20082006; 107: 1255\u201364.","DOI":"10.1182\/blood-2005-03-1306"},{"key":"2022061700300812900_B4","doi-asserted-by":"crossref","unstructured":"Verbeek S, Izon D, Hofhuis F, et al. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature\u20081995; 374: 70\u20134.","DOI":"10.1038\/374070a0"},{"key":"2022061700300812900_B5","doi-asserted-by":"crossref","unstructured":"Reya T, O'Riordan M, Okamura R, et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity\u20082000; 13: 15\u201324.","DOI":"10.1016\/S1074-7613(00)00004-2"},{"key":"2022061700300812900_B6","doi-asserted-by":"crossref","unstructured":"Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature\u20082003; 423: 409\u201314.","DOI":"10.1038\/nature01593"},{"key":"2022061700300812900_B7","doi-asserted-by":"crossref","unstructured":"Nusse R, Varmus HE. Wnt genes. Cell\u20081992; 69: 1073\u201387.","DOI":"10.1016\/0092-8674(92)90630-U"},{"key":"2022061700300812900_B8","doi-asserted-by":"crossref","unstructured":"Polakis P. Wnt signaling and cancer. Genes Dev\u20082000; 14: 1837\u201351.","DOI":"10.1101\/gad.14.15.1837"},{"key":"2022061700300812900_B9","doi-asserted-by":"crossref","unstructured":"Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol\u20081998; 14: 59\u201388.","DOI":"10.1146\/annurev.cellbio.14.1.59"},{"key":"2022061700300812900_B10","doi-asserted-by":"crossref","unstructured":"Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through \u03b2-catenin. Science\u20082002; 296: 1644\u20136.","DOI":"10.1126\/science.1071549"},{"key":"2022061700300812900_B11","doi-asserted-by":"crossref","unstructured":"Molenaar M, van de WM, Oosterwegel M, et al. XTcf-3 transcription factor mediates \u03b2-catenin-induced axis formation in Xenopus embryos. Cell\u20081996; 86: 391\u20139.","DOI":"10.1016\/S0092-8674(00)80112-9"},{"key":"2022061700300812900_B12","doi-asserted-by":"crossref","unstructured":"Behrens J, von Kries JP, Kuhl M, et al. Functional interaction of \u03b2-catenin with the transcription factor LEF-1. Nature\u20081996; 382: 638\u201342.","DOI":"10.1038\/382638a0"},{"key":"2022061700300812900_B13","doi-asserted-by":"crossref","unstructured":"Tetsu O, McCormick F. \u03b2-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature\u20081999; 398: 422\u20136.","DOI":"10.1038\/18884"},{"key":"2022061700300812900_B14","doi-asserted-by":"crossref","unstructured":"He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science\u20081998; 281: 1509\u201312.","DOI":"10.1126\/science.281.5382.1509"},{"key":"2022061700300812900_B15","doi-asserted-by":"crossref","unstructured":"van de Wetering M, Sancho E, Verweij C, et al. The \u03b2-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell\u20082002; 111: 241\u201350.","DOI":"10.1016\/S0092-8674(02)01014-0"},{"key":"2022061700300812900_B16","doi-asserted-by":"crossref","unstructured":"Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell\u20082000; 103: 311\u201320.","DOI":"10.1016\/S0092-8674(00)00122-7"},{"key":"2022061700300812900_B17","doi-asserted-by":"crossref","unstructured":"Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell\u20081996; 87: 159\u201370.","DOI":"10.1016\/S0092-8674(00)81333-1"},{"key":"2022061700300812900_B18","doi-asserted-by":"crossref","unstructured":"Wielenga VJ, Smits R, Korinek V, et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol\u20081999; 154: 515\u201323.","DOI":"10.1016\/S0002-9440(10)65297-2"},{"key":"2022061700300812900_B19","unstructured":"Boon EMJ, van der Neut R, van de Wetering M, Clevers H, Pals ST. Wnt signaling regulates expression of the receptor tyrosine kinase Met in colorectal cancer. Cancer Res\u20082002; 62: 5126\u20138."},{"key":"2022061700300812900_B20","doi-asserted-by":"crossref","unstructured":"Travis A, Amsterdam A, Belanger C, Grosschedl R. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor \u03b1 enhancer function [corrected]. Genes Dev\u20081991; 5: 880\u201394.","DOI":"10.1101\/gad.5.5.880"},{"key":"2022061700300812900_B21","doi-asserted-by":"crossref","unstructured":"van de Wetering M, Oosterwegel M, Dooijes D, Clevers H. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J\u20081991; 10: 123\u201332.","DOI":"10.1002\/j.1460-2075.1991.tb07928.x"},{"key":"2022061700300812900_B22","doi-asserted-by":"crossref","unstructured":"Schilham MW, Wilson A, Moerer P, et al. Critical involvement of Tcf-1 in expansion of thymocytes. J Immunol\u20081998; 161: 3984\u201391.","DOI":"10.4049\/jimmunol.161.8.3984"},{"key":"2022061700300812900_B23","doi-asserted-by":"crossref","unstructured":"Gounari F, Aifantis I, Khazaie K, et al. Somatic activation of \u03b2-catenin bypasses pre-TCR signaling and TCR selection in thymocyte development. Nat Immunol\u20082001; 2: 863\u20139.","DOI":"10.1038\/ni0901-863"},{"key":"2022061700300812900_B24","doi-asserted-by":"crossref","unstructured":"Ioannidis V, Beermann F, Clevers H, Held W. The \u03b2-catenin-TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival. Nat Immunol\u20082001; 2: 691\u20137.","DOI":"10.1038\/90623"},{"key":"2022061700300812900_B25","doi-asserted-by":"crossref","unstructured":"Kirstetter P, Anderson K, Porse BT, Jacobsen SE, Nerlov C. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol\u20082006; 7: 1048\u201356.","DOI":"10.1038\/ni1381"},{"key":"2022061700300812900_B26","doi-asserted-by":"crossref","unstructured":"Scheller M, Huelsken J, Rosenbauer F, et al. Hematopoietic stem cell and multilineage defects generated by constitutive \u03b2-catenin activation. Nat Immunol\u20082006; 7: 1037\u201347.","DOI":"10.1038\/ni1387"},{"key":"2022061700300812900_B27","doi-asserted-by":"crossref","unstructured":"Guo Z, Dose M, Kovalovsky D, et al. \u03b2-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation. Blood\u20082007; 109: 5463\u201372.","DOI":"10.1182\/blood-2006-11-059071"},{"key":"2022061700300812900_B28","doi-asserted-by":"crossref","unstructured":"Derksen PWB, Tjin E, Meijer HP, et al. Illegitimate WNT signaling promotes proliferation of multiple myeloma cells. Proc Natl Acad Sci U S A\u20082004; 101: 6122\u20137.","DOI":"10.1073\/pnas.0305855101"},{"key":"2022061700300812900_B29","doi-asserted-by":"crossref","unstructured":"Batlle E, Henderson JT, Beghtel H, et al. \u03b2-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB\/ephrinB. Cell\u20082002; 111: 251\u201363.","DOI":"10.1016\/S0092-8674(02)01015-2"},{"key":"2022061700300812900_B30","doi-asserted-by":"crossref","unstructured":"Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science\u20082004; 306: 269\u201371.","DOI":"10.1126\/science.1102160"},{"key":"2022061700300812900_B31","doi-asserted-by":"crossref","unstructured":"Blitzer JT, Nusse R. A critical role for endocytosis in Wnt signaling. BMC Cell Biol\u20082006; 7: 28.","DOI":"10.1186\/1471-2121-7-28"},{"key":"2022061700300812900_B32","doi-asserted-by":"crossref","unstructured":"McWhirter JR, Neuteboom ST, Wancewicz EV, et al. Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. Proc Natl Acad Sci U S A\u20081999; 96: 11464\u20139.","DOI":"10.1073\/pnas.96.20.11464"},{"key":"2022061700300812900_B33","doi-asserted-by":"crossref","unstructured":"Mazieres J, You L, He B, et al. Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene\u20082005; 24: 5396\u2013400.","DOI":"10.1038\/sj.onc.1208568"},{"key":"2022061700300812900_B34","doi-asserted-by":"crossref","unstructured":"Staal FJ, Clevers HC. Wnt signaling in the thymus. Curr Opin Immunol\u20082003; 15: 204\u20138.","DOI":"10.1016\/S0952-7915(03)00003-7"},{"key":"2022061700300812900_B35","doi-asserted-by":"crossref","unstructured":"Weerkamp F, van Dongen JJ, Staal FJ. Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia. Leukemia\u20082006; 20: 1197\u2013205.","DOI":"10.1038\/sj.leu.2404255"},{"key":"2022061700300812900_B36","doi-asserted-by":"crossref","unstructured":"Mansour MR, Linch DC, Foroni L, Goldstone AH, Gale RE. High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. Leukemia\u20082006; 20: 537\u20139.","DOI":"10.1038\/sj.leu.2404101"},{"key":"2022061700300812900_B37","doi-asserted-by":"crossref","unstructured":"Willert K, Brown JD, Danenberg E, et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature\u20082003; 423: 448\u201352.","DOI":"10.1038\/nature01611"},{"key":"2022061700300812900_B38","doi-asserted-by":"crossref","unstructured":"Meijer L, Skaltsounis AL, Magiatis P, et al. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol\u20082003; 10: 1255\u201366.","DOI":"10.1016\/j.chembiol.2003.11.010"},{"key":"2022061700300812900_B39","doi-asserted-by":"crossref","unstructured":"Hoshida Y, Hongyo T, Jia X, et al. Analysis of p53, K-ras, c-kit, and \u03b2-catenin gene mutations in sinonasal NK\/T cell lymphoma in northeast district of China. Cancer Sci\u20082003; 94: 297\u2013301.","DOI":"10.1111\/j.1349-7006.2003.tb01436.x"},{"key":"2022061700300812900_B40","doi-asserted-by":"crossref","unstructured":"Takahara M, Kishibe K, Bandoh N, Nonaka S, Harabuchi Y. P53, N- and K-Ras, and \u03b2-catenin gene mutations and prognostic factors in nasal NK\/T-cell lymphoma from Hokkaido, Japan. Hum Pathol\u20082004; 35: 86\u201395.","DOI":"10.1016\/j.humpath.2003.08.025"},{"key":"2022061700300812900_B41","doi-asserted-by":"crossref","unstructured":"Fujimuro M, Hayward SD. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3\u03b2. J Virol\u20082003; 77: 8019\u201330.","DOI":"10.1128\/JVI.77.14.8019-8030.2003"},{"key":"2022061700300812900_B42","doi-asserted-by":"crossref","unstructured":"Morrison JA, Klingelhutz AJ, Raab-Traub N. Epstein-Barr virus latent membrane protein 2A activates \u03b2-catenin signaling in epithelial cells. J Virol\u20082003; 77: 12276\u201384.","DOI":"10.1128\/JVI.77.22.12276-12284.2003"},{"key":"2022061700300812900_B43","doi-asserted-by":"crossref","unstructured":"Deloose ST, Smit LA, Pals FT, et al. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic\/plasmablastic diffuse large B-cell lymphoma. Leukemia\u20082005; 19: 851\u20135.","DOI":"10.1038\/sj.leu.2403709"},{"key":"2022061700300812900_B44","doi-asserted-by":"crossref","unstructured":"Lu D, Zhao Y, Tawatao R, et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A\u20082004; 101: 3118\u201323.","DOI":"10.1073\/pnas.0308648100"},{"key":"2022061700300812900_B45","doi-asserted-by":"crossref","unstructured":"Khan NI, Bradstock KF, Bendall LJ. Activation of Wnt\/\u03b2-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol\u20082007; 138: 338\u201348.","DOI":"10.1111\/j.1365-2141.2007.06667.x"},{"key":"2022061700300812900_B46","doi-asserted-by":"crossref","unstructured":"Roman-Gomez J, Cordeu L, Agirre X, et al. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood\u20082007; 109: 3462\u20139.","DOI":"10.1182\/blood-2006-09-047043"},{"key":"2022061700300812900_B47","doi-asserted-by":"crossref","unstructured":"Weerkamp F, Baert MR, Naber BA, et al. Wnt signaling in the thymus is regulated by differential expression of intracellular signaling molecules. Proc Natl Acad Sci U S A\u20082006; 103: 3322\u20136.","DOI":"10.1073\/pnas.0511299103"},{"key":"2022061700300812900_B48","doi-asserted-by":"crossref","unstructured":"Pongracz J, Hare K, Harman B, Anderson G, Jenkinson EJ. Thymic epithelial cells provide WNT signals to developing thymocytes. Eur J Immunol\u20082003; 33: 1949\u201356.","DOI":"10.1002\/eji.200323564"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/17\/6969\/2593030\/6969.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/17\/6969\/2593030\/6969.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T15:46:30Z","timestamp":1684511190000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/17\/6969\/540768\/Illegitimate-WNT-Pathway-Activation-by-Catenin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,28]]},"references-count":48,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2008,8,28]]},"published-print":{"date-parts":[[2008,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-1322","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6498447.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377132","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377129.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377135","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377132.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377129","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498447","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377135.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,28]]}}}